Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/15072
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Saen-Oon S. | |
dc.contributor.author | Kuno H. | |
dc.contributor.author | Hannongbua S. | |
dc.date.accessioned | 2021-04-05T04:32:29Z | - |
dc.date.available | 2021-04-05T04:32:29Z | - |
dc.date.issued | 2005 | |
dc.identifier.issn | 8873585 | |
dc.identifier.other | 2-s2.0-28644442414 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/15072 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-28644442414&doi=10.1002%2fprot.20690&partnerID=40&md5=bdfa20e816813bf3ae48971687134dd4 | |
dc.description.abstract | Two-layered and three-layered ONIOM calculations were performed to compare the binding energies of 8-Cl TIBO inhibitor when bound into the human immunodeficiency virus reverse transcriptase binding pocket and a Y181C variant. Both consisted of 20 residues within a radius of 15 Å. A combination of different methods [HP2/6-31G(d), B3LYP/6-31G(d,p), and PM3] were performed to take advantage of ONIOM's layering strategy analysis. The obtained results clearly indicate that the Y181C mutation reduces the binding affinity and stability of the inhibitor by approximately 8-9 kcal/mol as obtained from different combined MO:MO methods. Analyses regarding the energetic components of the interaction and deformation energies for 8-Cl TIBO inhibitor upon binding were also examined extensively. Additional calculations involving the interaction energies between 8-Cl TIBO with individual residues surrounding the binding pocket were performed at MP2/6-31G(d,p) and B3LYP/6-31G(d,p) levels of theory to gain more insight into the energetic differences of wild-type and Y181C mutant type at the atomistic level. © 2005 Wiley-Liss, Inc. | |
dc.subject | 4,5,6,7 tetrahydroimidazo 8 chloro 5 methyl (3 methyl 2 butenyl)imidazo | |
dc.subject | RNA directed DNA polymerase | |
dc.subject | RNA directed DNA polymerase inhibitor | |
dc.subject | unclassified drug | |
dc.subject | analytic method | |
dc.subject | article | |
dc.subject | binding affinity | |
dc.subject | calculation | |
dc.subject | comparative study | |
dc.subject | complex formation | |
dc.subject | drug binding site | |
dc.subject | drug protein binding | |
dc.subject | energy | |
dc.subject | Human immunodeficiency virus 1 | |
dc.subject | molecular stability | |
dc.subject | mutation | |
dc.subject | nonhuman | |
dc.subject | priority journal | |
dc.subject | quantum chemistry | |
dc.subject | wild type | |
dc.subject | Amino Acid Substitution | |
dc.subject | Dimerization | |
dc.subject | HIV-1 | |
dc.subject | Kinetics | |
dc.subject | Models, Molecular | |
dc.subject | Polymorphism, Single Nucleotide | |
dc.subject | Protein Structure, Secondary | |
dc.subject | Protein Subunits | |
dc.subject | Quantum Theory | |
dc.subject | Recombinant Proteins | |
dc.subject | Reverse Transcriptase Inhibitors | |
dc.subject | RNA-Directed DNA Polymerase | |
dc.subject | Thermodynamics | |
dc.subject | Human immunodeficiency virus | |
dc.subject | Human immunodeficiency virus 1 | |
dc.title | Binding energy analysis for wild-type and Y181C mutant HIV-1 RT/8-Cl TIBO complex structures: Quantum chemical calculations based on the ONIOM method | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Proteins: Structure, Function and Genetics. Vol 61, No.4 (2005), p.859-869 | |
dc.identifier.doi | 10.1002/prot.20690 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.